Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA, page-46

You're insane! This is literally just a research and testing lab with a handful of potentially cancer curing drugs in trail-phase only, and you're selling it @ $0.25c? They haven't even gone to market with a sellable product yet and you're proporting that the hype isn't real?

Maybe this will put things into perspective the next time you choose to capitalise on your 5% return -
The market cap of IMU is about $1.4billion. Compared to Roche (the largest cancer drug manfacturer in the world) @ AUD$480 billion, with an annual rev of AUD$90bil.
Basic math places their market cap at 340 times larger than IMU and gives us a solid indication of where the global market ceiling is for IMU IF their products work better than what's currently on the shelf. Assuming IMU grows just 10 times larger ($14bil market cap...highly probable) I can pay off my house and will probably receive a sufficient dividend that allows me to work part time. At 100 times larger ($140billion, not impossible) I'm retired in my 30's.
Either way, I'm 1.5 years into a 5 year hold period and have been averging-in ever since.

DYOR - Not financial advice - I could be dreaming or prophesying, who knows? Only time will tell.